Abstract
In order to evaluate the pharmacokinetics of ceftriaxone (Rocephin) in serum and gynecological tissues, intravenous injections of 2 g of ceftriaxone were administered to 3 groups, numbering 6 patients each, at 2-, 12-, and 24-hour intervals prior to surgery (hysterectomy and annexectomy) for noninfectious pathology. Even 24 h after intravenous administration of 2 g of ceftriaxone, both serum and gynecological tissue concentrations are well above the MIC90 for the majority of pathogens responsible for gynecological infections excepting Streptococcus faecalis and Bacteroides fragilis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
